Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
ASEAN Commercial Vehicles Market – Growth, Trends, and Forecast (2019 – 2024)
| Automotive | Published by: Mordor Intelligence | Market: |
| 96 pages | Published: 17-06-2019 |
- Automotive
- Mordor Intelligence
- 96 pages
- Published: 17-06-2019
Market Overview
The ASEAN commercial vehicles market (henceforth, referred to as the market studied) was valued at USD 45.85 billion in 2018, and it is anticipated to register a CAGR of about 4.41% during the forecast period (2019 – 2024).
The ASEAN countries witnessed a strong demand for heavy trucks and machinery, with the largest construction project pipeline, globally, with approximately USD 4.9 trillion worth of projects. Exports of heavy machinery, including trucks, from Singapore to the rest of the ASEAN region have grown steadily over the years. These exports are supported by the investments in construction projects in the ASEAN region.
Key developments in the market studied include product launches from significant manufacturers. In 2018, Mercedes-Benz launched AXOR 2528 R, IVECO launched the series 682 variant 4×2, Isuzu Astra Motor launched the new Isuzu GIGA truck, and Suzuki Indomobil Motor launched the facelift version of Mega Carry.
Some of the major players in the market studied are Toyota, Isuzu, Mitubishi, Hino, and Ford. In 2017, Toyota Motors dominated the ASEAN commercial vehicles market, with a market share of 35%, followed by Isuzu with a market share of 21%. The other players in the market studied include Daimler, TATA Motors, BAIC, and UD Trucks.
Scope of the Report
The ASEAN commercial vehicles market covers all the policies, initiatives and investment done by the governments and vehicle manufacturers across the world. The scope of the report includes:
Key Market Trends
Light Commercial Vehicle Segment is Leading the ASEAN Commercial Vehicles Market
The light commercial vehicles segment of the market studied was valued at USD 42.94 in 2018 and is expected to witness the fastest growth rate during the forecast period.
Under the light commercial vehicles (LCVs) segment, vehicles with a gross vehicle weight rating less than 16 metric ton have been considered, which includes pickup trucks, vans, light and medium trucks, and mini buses. Pickup trucks covered the highest share, covering more than 60% of LCVs sales in the ASEAN region in 2017, and continued to be the highest in the LCV segment during 2018, as well. Thailand, Indonesia, Malaysia, and Vietnam were the major ASEAN countries with high demand for pickup trucks, in 2017. However, during 2018, Vietnam’s pickup truck sales declined, due to the country’s implementation of stringent checks on imported vehicles, which resulted in import halt from neighboring countries, majorly from Thailand, Indonesia, and Japan, during first half of 2018.
Major players, such as Toyota, Isuzu, Mitsubishi, and Hino covered nearly more than 60% of the LCV segment of the market studied during 2017 and 2018. During the forecast period, the sales of LCVs are likely to continue to grow, owing to the following instances in the ASEAN countries, as automotive players in Thailand have geared their production plans in the coming years to capture the growing demand for light commercial vehicles across the ASEAN countries during the forecast period.
New models of LCVs have been significantly introduced in the ASEAN countries by the automobile manufacturers during 2018, to sustain in a highly competitive market, as well as to cater the growing demand for advanced vehicle features among the customers in the ASEAN countries.
Geography Trends
At present, Thailand is the market leader and it is likely to continue its lead in the ASEAN commercial vehicles market. Thailand is the biggest manufacturer in the region, and is planning to raise its annual production to 3.5 million units by 2025. The country faces competition from Indonesia, which has a goal of becoming the leading production hub. At present, the demand for commercial vehicles is declining in Vietnam, due to the new rule that came into effect (Vietnam finally eliminated its import tariff for automobiles from within the ASEAN countries from 30% on Jan, 1 2018). As a result, Toyota Motor and Honda Motor have stopped their exports to Vietnam since the beginning of the year, following the implementation of a rule that requires stringent checks on imported vehicles. The sales of commercial vehicles, such as trucks and buses, dropped by 16% to 23,364 units.
Singapore is a highly-developed free economy, with some of the positive factors being open and corruption-free business, followed by transparent legal frame work and many more. The construction sector (primarily buildings in the country) exhibited slow growth in the first quarter of 2017. Though new building construction activities were active in the past few years, they exhibited slow growth in the recent past. The decrease is mainly due to the downfall in contract prices.
Competitive Landscape
Some of the key players of the ASEAN commercial vehicles market are Toyota Motor Corporation, ISUZU, Mitsubishi Motor Corporation, and Hino Motors. The market studied is highly driven with factors, like joint-venture, partnerships, and growing demand of the industrial sectors and government’s development initiatives across the ASEAN countries. Product expansion facilities, free trade agreement within the countries, growing logistics, e-commerce, and construction sectors are the factors responsible for the increase in the respective market shares of key players in the region.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
4.5 Technological Trends
4.6 Government Regulations
4.7 Emission Regulations
5 MARKET SEGMENTATION
5.1 By Vehicle Type
5.1.1 Light Commercial Vehicles
5.1.2 Heavy-duty Commercial Vehicles
5.2 Geography
5.2.1 ASEAN Countries
5.2.1.1 Indonesia
5.2.1.2 Malaysia
5.2.1.3 Singapore
5.2.1.4 Thailand
5.2.1.5 Vietnam
5.2.1.6 Philippines
5.2.1.7 Rest of ASEAN Countries
6 COMPETITIVE LANDSCAPE
6.1 Vendor Market Share
6.2 Company Profiles
6.2.1 Isuzu Motors Ltd
6.2.2 Mitsubishi Motor Corporation
6.2.3 Honda Motor Company
6.2.4 Daihatsu Motor Co. Ltd
6.2.5 Ford Motor Company
6.2.6 Toyota Motor Corp.
6.2.7 Scania
6.2.8 Fiat Chrysler Automobiles
6.2.9 Hyundai Automobiles
6.2.10 IVECO (Industrial Vehicles Corporation)
6.2.11 Hino Motors Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
8 DISCLAIMER
MARKET SEGMENTATION
By Vehicle Type
Light Commercial Vehicles
Heavy-duty Commercial Vehicles
Geography
ASEAN Countries
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Philippines
Rest of ASEAN Countries
Asia-Pacific Fertilizers Market – Growth, Trends, and Forecast (2019 – 2024)
| Agriculture | Published by: Mordor Intelligence | Market: |
| 225 pages | Published: 17-06-2019 |
- Agriculture
- Mordor Intelligence
- 225 pages
- Published: 17-06-2019
Market Overview
The Asia-Pacific fertilizers market was valued at USD 8.87 billion in 2018, and it is expected to register a CAGR of 6.9% during the forecast period (2019-2024).
– In the Asia-Pacific fertilizers market, China is the largest consumer of fertilizers accounting for 52% of the total market.
– The major factors driving the market are technological innovations in the fertilizer market, growth in the demand for micronutrient fertilizer, decrease in per capita arable land, and increase in demand for food.
– High production cost and growing demand for biofertilizers are restraining the growth of the market.
Scope of the Report
The study analyzes the current scenario of the Asia-Pacific fertilizers market. It covers extensive segmentation on product type and by country, along with forecast up to 2023. In addition to this, an overview of the key players in the Asia-Pacific fertilizers market is also included in the report. The report also includes regulatory analysis and detailed value chain analysis of the countries in the Asia-Pacific region.
Key Market Trends
Decreasing Per Capita Arable Land and Increasing Demand for Food
Population in the Asia-Pacific region is increasing at a rapid rate. This growing population is adding to the food demand. Supplying food to this growing population has become a threat. On the other hand, arable land is declining, due to industrialization and urbanization. Fertilizers have been used for a long time to increase the productivity of crops. This adequate and balanced use of fertilizer may help in feeding the growing population from the available cultivable land. Hence, the major factors driving the demand for fertilizers include the need for crop intensification while pursuing increasingly sustainable practices, and seeking biological alternatives to boost production with decreased pressure on the environment to close the yield gap.
China Dominates the Asia-Pacific Fertilizers Market
China feeds 22% of the world’s population with merely 12.68% of the arable land. The major crops that are grown in China are rice, wheat, potatoes, corn, peanuts, tea, millet, barley, apples, cotton, and oilseed. According to the China Agriculture Industry Development report, China has a goal to become self-sufficient in staple foods, like rice, corn, and wheat, by 2035. The government ensures a minimum price for the grains and provides storage for them in the government silos. Farmers in the country are also using fertilizers and pesticides to increase the production. The most important agricultural area in the country is the North China Plain, which extends across several provinces. China is the largest consumer of fertilizers in the Asia-Pacific region and represented around 52% share in the Asia-Pacific fertilizers market in 2017.
Competitive Landscape
The Asia-Pacific fertilizers market is highly fragmented with the top five market players cornering very minimal share in the market. The development of regional markets and increasing shares of local players in the foreign direct investment are the major factors promoting the fragmented nature of the market. Maximum competitor activities are recorded in Indonesia and China.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of New Entrants
4.4.4 Threat from Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Type
5.1.1 Nitrogenous
5.1.1.1 Urea
5.1.1.2 Calcium Ammonium Nitrate (CAN)
5.1.1.3 Ammonium Nitrate
5.1.1.4 Ammonium Sulfate
5.1.1.5 Anhydrous Ammonia
5.1.1.6 Other Nitrogenous Fertilizers
5.1.2 Phosphatic
5.1.2.1 Monoammonium Phosphate (MAP)
5.1.2.2 Diammonium Phosphate (DAP)
5.1.2.3 Triple Superphosphate (TSP)
5.1.2.4 Other Phosphatic Fertilizers
5.1.3 Potassic
5.1.3.1 Muriate of Potash (MOP)
5.1.3.2 Other Potassic Fertilizers
5.1.4 Other Types
5.2 Application
5.2.1 Grains and Cereals
5.2.2 Pulses and Oilseeds
5.2.3 Fruits and Vegetables
5.2.4 Plantation Crops
5.2.5 Other Crops
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 Indonesia
5.3.1.6 Vietnam
5.3.1.7 Thailand
5.3.1.8 Philippines
5.3.1.9 Rest of Asia-Pacific
6 COMPETITIVE LANDSCAPE
6.1 Vendor Market Share
6.2 Mergers and Acquisitions
6.3 Company Profiles
6.3.1 China BlueChemical Ltd
6.3.2 Sinofert Holding Ltd
6.3.3 PT Petrokimia Gresik
6.3.4 Hubeu Xin Yanf Feng Fertilizer Industry Limited
6.3.5 Yara International
6.3.6 Groupe OCP
6.3.7 ICL- Israel Chemicals Ltd
6.3.8 Haifa Chemicals Ltd
6.3.9 PT Pupuk Iskandar Muda
6.3.10 PT Pupuk Kujang
6.3.11 PT Pupuk Kalimantan Timur
6.3.12 PT Pupuk Sriwidjaya Palembang
6.3.13 The Mosaic Company
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Type
Nitrogenous
Urea
Calcium Ammonium Nitrate (CAN)
Ammonium Nitrate
Ammonium Sulfate
Anhydrous Ammonia
Other Nitrogenous Fertilizers
Phosphatic
Monoammonium Phosphate (MAP)
Diammonium Phosphate (DAP)
Triple Superphosphate (TSP)
Other Phosphatic Fertilizers
Potassic
Muriate of Potash (MOP)
Other Potassic Fertilizers
Other Types
Application
Grains and Cereals
Pulses and Oilseeds
Fruits and Vegetables
Plantation Crops
Other Crops
Geography
Asia-Pacific
China
Japan
India
Australia
Indonesia
Vietnam
Thailand
Philippines
Rest of Asia-Pacific
Diabetes Care Devices Market – Growth, Trends, and Forecast (2012 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 17-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 17-06-2019
Market Overview
The global diabetes care devices market is expected to register a CAGR of about 6.8% during the forecast period (2019 – 2023).
Asia-Pacific is anticipated to dominate the market during the forecast period, owing to rising prevalence of obesity in the region.
There has been a significant rise in insulin delivery systems technology, from insulin injections to insulin pumps.
Technological innovations and advances give much convenience in measuring the blood glucose levels. One such advancement in monitoring the blood glucose levels is established with continuous glucose monitoring devices.
Scope of the Report
The global diabetes care devices market is segmented by management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood glucose (hospital and personal use) and continuous glucose monitoring), and geography.
Key Market Trends
Rising Prevalence of Diabetes
As per a WHO report, the global prevalence of diabetes among adults of over 18 years accelerated from about 4.7%, in 1980, to over 8.5%, in 2014.
Diabetes prevalence has been rising rapidly in the middle- and low-income countries. In 2015, about 1.6 million deaths were directly associated with diabetes, which was around 2.2 million in 2012.
Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes is likely to be the seventh-leading cause of death by 2030.
The growing prevalence of diabetes is the major driver for the global diabetes care devices market. Additionally, rising awareness regarding diabetes care, growing prevalence of obesity, and technological advancements are further driving the market for diabetes care devices.
North America to Dominate the Monitoring Devices Segment
The factors attributing to the North American market growth is the rising prevalence of diabetes, caused mainly due to urbanization and sedentary lifestyles.
Asia-Pacific is anticipated to grow tremendously during the forecast period, owing to factors, such as a high prevalence of diabetes, growing obese population, and government initiatives of raising awareness regarding diabetic care.
Competitive Landscape
There have been constant innovations driven by manufacturers to compete and struggle in the market. The major players, such as Abbott and Medtronic, resort to inorganic market strategies, such as mergers and acquisitions, to establish market dominance, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies. Examples of few strategic outcomes include:
In March 2018, Medtronic PLC received the US Food and Drug Administration (FDA) approval for Guardian(TM) Connect continuous glucose monitoring (CGM) system, for diabetics aged between aged between 14-75 years.
In January 2018, Abbott announced that the FreeStyleLibre System, the company’s revolutionary new continuous glucose monitoring (CGM) system, was available to Medicare patients in the United States.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Monitoring Devices
5.1.1 Self-Monitoring Blood Glucose Devices
5.1.1.1 By Component (Value and Volume, 2012 – 2024)
5.1.1.1.1 Glucometer Devices
5.1.1.1.2 Test Strips
5.1.1.1.3 Lancets
5.1.1.2 By End User
5.1.1.2.1 Hospital (Value and Volume, 2012 – 2024)
5.1.1.2.1.1 Glucometer Devices
5.1.1.2.1.2 Test Strips
5.1.1.2.1.3 Lancets
5.1.1.2.2 Personal (Value and Volume, 2012 – 2024)
5.1.1.2.2.1 Glucometer Devices
5.1.1.2.2.2 Test Strips
5.1.1.2.2.3 Lancets
5.1.2 Continuous Blood Glucose Monitoring
5.1.2.1 By Component (Value and Volume, 2012 – 2024)
5.1.2.1.1 Sensors
5.1.2.1.2 Receivers
5.2 Management Devices
5.2.1 Insulin Pump
5.2.1.1 Insulin Pump Device
5.2.1.2 Insulin Pump Reservoir
5.2.1.3 Infusion Set
5.2.2 Insulin Syringes
5.2.3 Insulin Cartridges
5.2.4 Disposable Pens
5.2.5 Jet Injectors
5.3 Geography
5.3.1 North America
5.3.1.1 United States (Value and Volume, 2012 – 2024)
5.3.1.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.1.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.1.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.1.2 Canada (Value and Volume, 2012 – 2024)
5.3.1.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.1.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.1.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.1.3 Rest of North America (Value and Volume, 2012 – 2024)
5.3.1.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.1.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.1.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2 Europe
5.3.2.1 France (Value and Volume, 2012 – 2024)
5.3.2.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2.2 Germany (Value and Volume, 2012 – 2024)
5.3.2.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2.3 Italy (Value and Volume, 2012 – 2024)
5.3.2.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2.4 Spain (Value and Volume, 2012 – 2024)
5.3.2.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2.5 United Kingdom (Value and Volume, 2012 – 2024)
5.3.2.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2.6 Russia (Value and Volume, 2012 – 2024)
5.3.2.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.2.7 Rest of Europe (Value and Volume, 2012 – 2024)
5.3.2.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.2.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.2.7.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.3 Latin America
5.3.3.1 Mexico (Value and Volume, 2012 – 2024)
5.3.3.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.3.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.3.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.3.2 Brazil (Value and Volume, 2012 – 2024)
5.3.3.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.3.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.3.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.3.3 Rest of Latin America (Value and Volume, 2012 – 2024)
5.3.3.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.3.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.3.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4 Asia-Pacific
5.3.4.1 Japan (Value and Volume, 2012 – 2024)
5.3.4.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.2 South Korea (Value and Volume, 2012 – 2024)
5.3.4.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.3 China (Value and Volume, 2012 – 2024)
5.3.4.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.4 India (Value and Volume, 2012 – 2024)
5.3.4.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.5 Australia (Value and Volume, 2012 – 2024)
5.3.4.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.6 Vietnam (Value and Volume, 2012 – 2024)
5.3.4.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.7 Malaysia (Value and Volume, 2012 – 2024)
5.3.4.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.7.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.8 Indonesia (Value and Volume, 2012 – 2024)
5.3.4.8.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.8.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.8.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.9 Philippines (Value and Volume, 2012 – 2024)
5.3.4.9.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.9.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.9.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.10 Thailand (Value and Volume, 2012 – 2024)
5.3.4.10.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.10.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.10.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2012 – 2024)
5.3.4.11.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.4.11.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.4.11.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.5 Middle East & Africa
5.3.5.1 Saudi Arabia (Value and Volume, 2012 – 2024)
5.3.5.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.5.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.5.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.5.2 Iran (Value and Volume, 2012 – 2024)
5.3.5.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.5.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.5.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.5.3 Egypt (Value and Volume, 2012 – 2024)
5.3.5.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.5.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.5.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.5.4 Oman (Value and Volume, 2012 – 2024)
5.3.5.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.5.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.5.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.5.5 South Africa (Value and Volume, 2012 – 2024)
5.3.5.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.5.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.5.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
5.3.5.6 Rest of Middle & Africa (Value and Volume, 2012 – 2024)
5.3.5.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
5.3.5.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
5.3.5.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
6 MARKET INDICATORS
6.1 Type 1 Diabetes Population (2012-2024)
6.2 Type 2 Diabetes Population (2012-2024)
7 COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Abbott Diabetes Care
7.1.2 Roche
7.1.3 Johnson & Johnson
7.1.4 Dexcom
7.1.5 Medtronic
7.1.6 Arkray
7.1.7 Ascensia Diabetes Care
7.1.8 Agamatrix Inc.
7.1.9 Bionime Corporation
7.1.10 Acon
7.1.11 Medisana
7.1.12 Trivida
7.1.13 Rossmax
7.2 COMPANY SHARE ANALYSIS
7.2.1 Roche
7.2.2 Johnson & Johnson
7.2.3 Abbott Diabetes Care
7.2.4 Dexcom
7.2.5 Medtronic
7.2.6 Novo Nordisk
7.2.7 Eli Lilly
7.2.8 Sanofi
7.2.9 Others
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Monitoring Devices
Self-Monitoring Blood Glucose Devices
By Component (Value and Volume, 2012 – 2024)
Glucometer Devices
Test Strips
Lancets
By End User
Hospital (Value and Volume, 2012 – 2024)
Glucometer Devices
Test Strips
Lancets
Personal (Value and Volume, 2012 – 2024)
Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring
By Component (Value and Volume, 2012 – 2024)
Sensors
Receivers
Management Devices
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Insulin Cartridges
Disposable Pens
Jet Injectors
Geography
North America
United States (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Canada (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Rest of North America (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Europe
France (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Germany (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Italy (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Spain (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
United Kingdom (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Russia (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Rest of Europe (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Latin America
Mexico (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Brazil (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Rest of Latin America (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Asia-Pacific
Japan (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
South Korea (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
China (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
India (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)Australia (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Vietnam (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Malaysia (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Indonesia (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Philippines (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Thailand (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Rest of Asia-Pacific (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Middle East & Africa
Saudi Arabia (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Iran (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Egypt (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Oman (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
South Africa (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Rest of Middle & Africa (Value and Volume, 2012 – 2024)
By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
Global Rice Seed Market – Growth, Trends, and Forecast (2019 – 2024)
| Agriculture | Published by: Mordor Intelligence | Market: |
| 141 pages | Published: 17-06-2019 |
- Agriculture
- Mordor Intelligence
- 141 pages
- Published: 17-06-2019
Market Overview
The rice seed market was valued at USD 7,232.9 million in 2018 and is projected to reach USD 10,944.6 million in 2024, registering a CAGR of 7.35% during the forecast period. The two most popular varieties of rice grown globally are, Oryza sativa and Oryza glaberrima, of which Oryza sativa L, the most widely grown rice, is the staple food of an estimated 3.5 billion people worldwide. Rice is the staple crop for over half the world’s population. China and India, alone, account for 50% of the rice grown and consumed. Rice provides up to 50% of the dietary caloric supply for millions living in poverty in Asia, and therefore, rice is critical for food security. It is also becoming an important food staple in both Latin America and Africa. In many countries of Asia-Pacific, such as Bangladesh and the Philippines, per capita consumption of rice continues to rise across income groups in both urban and rural areas.
Scope of the Report
The report presents a wide-range analysis of the market share, size, and trends of the rice seed market. The market operates in a B-to-C level and market sizing has been done at the consumer level. It contains an analysis of the various aspects of the rice seed market, globally. The study includes the market dynamics and geographical importance of the market.
Key Market Trends
Increasing Trade in Rice Seed
Around 9% of the total rice produced is traded globally. This share has been improving over the years. Varying national laws and regulations and lack of official recognition of HYV seeds available are observed in a large number of countries. However, with increasing rice seed trade between countries, these bottlenecks are likely to reduce. Rice trade developed mainly around Asia. There has been an increase in the number of projects that facilitate rice seed trade. For instance, the project RISTE aims at developing and enabling the environment to promote seeds trade and knowledge – sharing on HYV rice seeds between India and Bangladesh. This is likely to benefit both countries.
Increasing Rice Consumption in the Asia – Pacific Region
About 90% of the world’s rice is grown in the Asia-Pacific region, which is endowed with the wet environment suitable for rice cultivation. Rice-based farming is the main economic activity for hundreds of millions of poor rural farmers in the region. China is the largest producer and consumer of rice seeds, followed by India and Vietnam. China’s National Rice Research Institute is considering tapping into the seed markets in Southeast Asia, Africa, and South America, by promoting its hybrid rice varieties over the next five years.
Competitive Landscape
In the last few years, Kaveri Seeds, Bayer CropScience, Rasi Seeds, Yuan Longping Hitech, and SL Agritech have been the most active players in terms of strategic development in the rice seed industry. Most of the companies are gaining market share by developing high–yielding, disease-resistant, and hybrid rice seed variety, suited to the local growing condition of various countries. Bayer CropScience has acquired 59% of the share in the Indian hybrid rice seed market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Force Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitute Products
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Geography
5.1.1 North America
5.1.1.1 United States
5.1.1.2 Canada
5.1.1.3 Mexico
5.1.1.4 Rest of North America
5.1.2 Europe
5.1.2.1 Germany
5.1.2.2 United Kingdom
5.1.2.3 France
5.1.2.4 Spain
5.1.2.5 Italy
5.1.2.6 Rest of Europe
5.1.3 Asia – Pacific
5.1.3.1 China
5.1.3.2 Japan
5.1.3.3 India
5.1.3.4 Pakistan
5.1.3.5 Thailand
5.1.3.6 Vietnam
5.1.3.7 Rest of Asia – Pacific
5.1.4 South America
5.1.4.1 Brazil
5.1.4.2 Argentina
5.1.4.3 Rest of South America
5.1.5 Africa
5.1.5.1 Egypt
5.1.5.2 South Africa
5.1.5.3 Rest of Africa
6 COMPETITIVE LANDSCAPE
6.1 Most Adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 Syngenta AG
6.3.2 Bayer CropScience SE
6.3.3 Dow-DuPont Inc.
6.3.4 Monsanto
6.3.5 Longping High-Tech
6.3.6 SL Agritech
6.3.7 Advanta Seeds
6.3.8 Nuziveedu
6.3.9 Kaveri Seeds
6.3.10 Mahyco Seeds
6.3.11 RiceTec Inc.
6.3.12 China National Seed group
6.3.13 Advanced Chemical Indutries
6.3.14 Hefei Fengle Seed Co. Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Geography
North America
United States
Canada
Mexico
Rest of North America
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia – Pacific
China
Japan
India
Pakistan
Thailand
Vietnam
Rest of Asia – Pacific
South America
Brazil
Argentina
Rest of South America
Africa
Egypt
South Africa
Rest of Africa
Philippines Structural Insulated Panels Market – Growth, Trends, and Forecast (2019 – 2024)
| Chemical & Materials | Published by: Mordor Intelligence | Market: |
| 65 pages | Published: 17-06-2019 |
- Chemical & Materials
- Mordor Intelligence
- 65 pages
- Published: 17-06-2019
Market Overview
The Philippines structural insulated panels market is expected to grow moderately, at an estimated CAGR of 4.21%, during 2019-2024. The market is driven by the increasing demand from the construction industry.
Increasing cold storage applications are likely to act as a market opportunity for market growth in the future.
In 2017, the building wall application dominated the market with a share of around 60%.
Key Market Trends
Increasing Demand from the Construction Industry
The rise in building and construction activities is the prominent factors augmenting the demand for structural insulated panels (SIPs).
Among the various non-conventional insulations being introduced to the construction industry, as the next-generation thermal insulation, SIPs appear to be one of the most promising insulation materials with the significant thermal insulating capacity.
Time and cost are the two parameters associated with construction activity that has long been considered as constraints for the growth of the industry. Overcoming these constraint has been one of the major hurdles in the country. Structural insulation panels act as one of the major solutions for these problems.
Number of constructions in the country registered a growth of 2.7% in 2017, with the total number of constructions generated from approved building permits reaching 152,01,2 and the non-residential constructions increased by 19.6%, reaching 21,349 constructions in 2017.
Furthermore, increasing construction and infrastructure spending in the country has been increasing from the past few years. In August 2018, government spending on infrastructure increased by 71%, to PHP 68.4 billion from PHP 40.1 billion, in the same month of 2017.
All the factors mentioned above increase the demand for the structural insulated panels in the construction sector, and are expected to drive the market in the coming years.
Increasing Demand for the Building Walls
Structural insulated wall panels are generally available in thicknesses of 4-1/2 inches and 6-1/2 inches. Manufacturing of curved wall panels are possible and it is often more practical to use stud framing for non-orthogonal geometries.
The whole wall R-value of a wall assembly is currently the best and the most followed method of quantifying the total thermal performance. The whole wall R-value takes the resistance of heat flown through an opaque cross sectional area of the insulation and structure into the accounts while the total loss of energy at the interfaces of the wall with the roof and floor are accounted.
The whole wall R-value of a 4-inch structural insulated wall panel is 14, whereas for a 2×4 wall it is less than 10. The whole wall R-value of a 2×6 wall is between 11 and 13.7, depending on the quality of the installation of batt insulation.
The elimination of thermal bridging and a more air tight envelope contributes to the higher whole wall R-value of structural insulated wall panels, compared to the conventional metal and wood stud walls.
The total volume of the panels used as structural insulated wall panels is much higher, compared to the volume of the panels used as structural insulated roof panels.
Philippines experienced a GDP growth rate of 6.7% in 2017, ranking the highest among the ASEAN nations, aided by the increasing consumption and higher investments, which, in turn, led to a strong rebound in export earnings.
All the aforementioned factors, in turn, increase the demand for the structural insulated panels.
Competitive Landscape
The Philippine structural insulated panels market is partly consolidated, with the top 10 players accounting for 60-70% of the total market share. The major companies include Ultra Insulated Panel Systems Corporation, VBLLU Inc., and iSTEEL Inc., among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Increasing Demand from the Construction Sector
4.2 Restraints
4.2.1 Advancements in Building Technologies, such as Modular Construction Techniques
4.3 Industry Value-Chain Analysis
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product
5.1.1 Expanded Polystyrene (EPS) Panels
5.1.2 Rigid Polyurethane (PUR) and Rigid Polyisocyanurate (PIR) Panels
5.1.3 Glass Wool Panels
5.1.4 Other Products (Extruded Polystyrene Foam)
5.2 Application
5.2.1 Building Wall
5.2.2 Building Roof
5.2.3 Cold Storage
6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 ENERCON Specialty Building Systems Corporation
6.4.2 iSTEEL Inc.
6.4.3 Kingspan Group
6.4.4 Metalink
6.4.5 Shanghai Seventrust Industry Co. Ltd
6.4.6 SRC Intl. Panel System Inc.
6.4.7 Supersonic Manufacturing Inc.
6.4.8 Ultra Insulated Panel Systems Corporation (UIPSC)�
6.4.9 Union Galvasteel Corporation (UGC)
6.4.10 VBLLU Inc.
6.4.11 Thermasip
6.4.12 Ultra Insulated Panel Systems Corporation
6.4.13 VBLLU Inc.
6.4.14 iSTEEL, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Increasing Cold Storage Applications
MARKET SEGMENTATION
Product
Expanded Polystyrene (EPS) Panels
Rigid Polyurethane (PUR) and Rigid Polyisocyanurate (PIR) Panels
Glass Wool Panels
Other Products (Extruded Polystyrene Foam)
Application
Building Wall
Building Roof
Cold Storage
Syngas Market – Growth, Trends, and Forecast (2019 – 2024)
| Chemical & Materials | Published by: Mordor Intelligence | Market: |
| 150 pages | Published: 17-06-2019 |
- Chemical & Materials
- Mordor Intelligence
- 150 pages
- Published: 17-06-2019
Market Overview
The market for syngas is expected to grow at a CAGR of 11.02 % during the forecast period of 2019 – 2024. Major factors driving the market studied are feedstock flexibility for syngas production and the growing chemical industry. High capital investment and funding are expected to hinder the growth of the market studied.
The demand from the chemical industry dominated the market in 2017 and is expected to grow during the forecast period, owing to the increasing demand from the chemical industry. The market is further expected to grow, owing to the rising demand from gaseous fuels.
Development of underground coal gasification technology is likely to act as an opportunity in the future.
Asia-Pacific dominated the market across the globe, with the largest consumption, holding a lion’s share in the market, followed by North America and Europe.
Key Market Trends
Increasing Demand from Chemical Industry
Syngas is one of the widely used fuel gas mixtures, which primarily consists of carbon monoxide and hydrogen. It is often used as fuel in engines and its energy density is about half of natural gas.
Syngas is used to create synthetic natural gas (SNG). It is seen as a viable alternative for usage as fuel in the form of LNG or CNG and it can be used in road, rail, marine, and other transport.
Syngas can be used to fuel gas engines for various purposes, such as power supply, where it can be used for benefits like low energy costs, stability, and predictability.
Syngas can be used effectively for both heat and electrical supply, as it can provide high electrical efficiency compared to other power generation technologies, such as steam turbines. It requires less pressure and its disposal is easier when it cannot be used for power or heat generation.
The Demand from Asia-Pacific to Expand at a Lucrative Rate
Asia-Pacific dominated the global market share in 2017, with rising demand from the chemical industry, primarily from refineries. China’s refinery capacity is about 14,177 thousand barrels per day, which constitutes 14.6% of the world’s refining capacity. China is a hub for chemical processing, accounting for the majority of chemicals produced, globally. With the growing global demand for various chemicals, the demand for syngas from this sector is expected to increase significantly during the forecast period. The Chinese oil and gas sector is dominated by four national and provincial oil companies, which include PetroChina, Sinopec, China National Offshore Oil Corporation (CNOOC), and Yanchang Petroleum. PetroChina and Sinopec account for 31% and 45% of the total crude oil refining capacity in the country, respectively. Moreover, the consumption of both liquid and gaseous fuels is increasing exponentially in the country. This is expected to augment the syngas market’s growth over the forecast period. India was the third largest oil consumer in the world in 2017. The country has 600 million metric ton (MMT) of oil reserves and 43.8 trillion cubic feet of natural gas reserves. However, it is focusing on increasing its domestic production. India’s refinery capacity is about 4,620 thousand barrel per day, constituting about 4.7% of the world’s refining capacity. In India, the demand for increasing refining capacity is primarily due to the growing demand for fuel. Increasing sales of passenger cars, replacement of LPG as a cooking fuel, increasing urbanization, along with demand for infrastructure and consumer goods, are some of the factors augmenting the demand for fuel. The aforementioned factors are projected to increase the consumption of syngas during the forecast period.
Competitive Landscape
The global syngas market is fragmented, with key players including Air Products and Chemicals Inc., the Linde Group, L‘Air Liquide SA, and Sasol. The other major players in the market include Haldor Topsoe A/S, Shell, KBR Inc., etc.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Feedstock Flexibility for Syngas Production
4.1.2 Growing Demand for Electricity
4.1.3 Growing Chemical Industry
4.2 Restraints
4.2.1 High Capital Investment and Funding
4.3 Industry Value-Chain Analysis
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 End-user Industry
5.1.1 Power Generation
5.1.2 Chemicals
5.1.2.1 Methanol
5.1.2.2 Ammonia
5.1.2.3 Oxo Chemicals
5.1.2.4 N-Butanol
5.1.2.5 Hydrogen
5.1.2.6 Dimethyl Ether
5.1.3 Liquid Fuels
5.1.4 Gaseous Fuels
5.2 Feedstock
5.2.1 Coal
5.2.2 Natural Gas
5.2.3 Petroleum
5.2.4 Pet-coke
5.2.5 Biomass
5.3 Technology
5.3.1 Steam Reforming
5.3.2 Partial Oxidation
5.3.3 Auto-thermal Reforming
5.3.4 Combined or Two-step Reforming
5.3.5 Biomass Gasification
5.4 Gasifier Type
5.4.1 Fixed Bed
5.4.2 Entrained Flow
5.4.3 Fluidized Bed
5.5 Geography
5.5.1 Asia-Pacific
5.5.1.1 China
5.5.1.2 India
5.5.1.3 Japan
5.5.1.4 South Korea
5.5.1.5 Australia & New Zealand
5.5.1.6 Rest of Asia-Pacific
5.5.2 North America
5.5.2.1 US
5.5.2.2 Canada
5.5.2.3 Mexico
5.5.2.4 Rest of North America
5.5.3 Europe
5.5.3.1 Germany
5.5.3.2 UK
5.5.3.3 Italy
5.5.3.4 France
5.5.3.5 Spain
5.5.3.6 Russia
5.5.3.7 Rest of Europe
5.5.4 South America
5.5.4.1 Brazil
5.5.4.2 Argentina
5.5.4.3 Rest of South America
5.5.5 Middle East & Africa
5.5.5.1 Saudi Arabia
5.5.5.2 South Africa
5.5.5.3 Rest of Middle East & Africa
6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Air Products & Chemicals Inc.
6.4.2 Air Liquide
6.4.3 BASF SE
6.4.4 BP PLC
6.4.5 ECUST
6.4.6 John Wood Group PLC
6.4.7 General Electric
6.4.8 Haldor Topsoe AS
6.4.9 KBR Inc.
6.4.10 The Linde Group
6.4.11 Royal Dutch Shell
6.4.12 Sasol
6.4.13 Siemens AG
6.4.14 TechnipFMC PLC
6.4.15 Yara
6.4.16 SynGas Technology LLC
6.4.17 OXEA GmbH
6.4.18 Dakota Gasification Company
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Utilization of Biomass and Municipal Waste
7.2 Development of Underground Coal Gasification Technology
MARKET SEGMENTATION
End-user Industry
Power Generation
Chemicals
Methanol
Ammonia
Oxo Chemicals
N-Butanol
Hydrogen
Dimethyl Ether
Liquid Fuels
Gaseous Fuels
Feedstock
Coal
Natural Gas
Petroleum
Pet-coke
Biomass
Technology
Steam Reforming
Partial Oxidation
Auto-thermal Reforming
Combined or Two-step Reforming
Biomass Gasification
Gasifier Type
Fixed Bed
Entrained Flow
Fluidized Bed
Geography
Asia-Pacific
China
India
Japan
South Korea
Australia & New Zealand
Rest of Asia-Pacific
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
Italy
France
Spain
Russia
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa